This past spring, Congress passed a number of important tax provisions that will impact how taxpayers manage their assets and estates. One of particular significance is the American Tax Relief Act of ...

An update from Atara Biotherapeutics ( ($ATRA) ) is now available. On December 30, 2025, Atara Biotherapeutics amended its commercialization ...

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product ...

Atara Biotherapeutics Inc (NASDAQ:ATRA) shares are trading higher by 30.7% to $8.87 Wednesday morning. The company announced a $36 million registered direct offering of 758,900 shares at $8.25 per ...

Atara Biotherapeutics (ATRA) shares rallied 10% in the last trading session to close at $11.82. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a dismal survival rate. Persistent activation of pancreatic stellate cells (PSCs) can perturb the biomechanical ...

In our April 2013 article for Trusts & Estates, “Life Insurance After ATRA,” we considered how the use of life insurance as a tool for both personal financial planning and estate planning might be ...